Top

Published in:

Open Access 01-01-2016 | Editorial Comment

Upgrading and replacement in CRT devices: experience counts

Author: W.G. de Voogt

Published in: Netherlands Heart Journal | Issue 1/2016

Excerpt

Cardiac resynchronisation therapy has proven to be highly effective in patients with heart failure and an asynchronous contraction pattern of the left ventricle, due to late activation of the posterolateral wall with left bundle branch block configuration on the ECG of more than 150 ms [1]. …

Sipahi I, Chou JC, Hyden M, et al. Effect of QRS morphology on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials. Am Heart J. 2012;163:260–7.PubMedPubMedCentralCrossRef

Bogale N, Witte K, Priori S, et al. The European cardiac resynchronization therapy survey: comparison of outcomes between de novo cardiac resynchronization therapy implantations and upgrades. Eur J Heart Fail. 2011;13:974–83.PubMedCrossRef

Poole JE, Gleva MJ, Mela T, et al. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry. Circulation. 2010;122:1553–61.PubMedCrossRef

Eberhardt F, Bode F, Bonnemeier H, et al. Long term complications in single and dual chamber pacing are influenced by surgical experience and patient morbidity. Heart. 2005;91:500–6.PubMedPubMedCentralCrossRef

ter Horst IAH, Kuijpers Y, Sant J van ’t, et al. Are CRT upgrade procedures more complex and associated with more complications than de novo CRT implantations?’ A single centre experience. Neth Heart J. 2016;24 doi: 10.1007/s12471-015-0771-9.

Title: Upgrading and replacement in CRT devices: experience counts
Author: W.G. de Voogt
Publication date: 01-01-2016
Publisher: Bohn Stafleu van Loghum
Published in: Netherlands Heart Journal / Issue 1/2016
Print ISSN: 1568-5888
Electronic ISSN: 1876-6250
DOI: https://doi.org/10.1007/s12471-015-0772-8

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Upgrading and replacement in CRT devices: experience counts

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2016

“Are CRT upgrade procedures more complex and associated with more complications than de novo CRT implantations?” A single centre experience

The influence of right ventricular stimulation on acute response to cardiac resynchronisation therapy

Patient-reported health status prior to cardiac resynchronisation therapy identifies patients at risk for poor survival and prolonged hospital stays

Echo response and clinical outcome in CRT patients

Patients predict their own outcome with CRT

Pathophysiology of dyssynchrony: of squirrels and broken bones

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page